Experts agree that most patients younger than 65 should be treated with surgery instead of TAVR. According to a new real-world analysis, however, more and more of these patients are undergoing TAVR.
This new catheter-based device for lymphatic drainage showed early potential to be an effective treatment option for acute decompensated heart failure.
Food and Drug Administration Commissioner Marty Makary is about to become a former FDA chief. The departure comes as no surprise since President Donald Trump OK’d a plan to fire him last week.
Concerns about radiation are believed to be a major reason so few women pursue a career in interventional cardiology. Are they right to be worried? SCAI hopes its new analysis can shed some light on this topic.
Experts see enormous potential in the delivery of genicular artery embolization, with millions impacted and growing case numbers given an aging population.
Jennifer Palmer died at age 34 after cancer spread to her bones, with her family subsequently suing a New York radiologist, alleging she missed sings on an MRI.
ACR, the American Society of Neuroradiology, all 50 state medical societies and numerous others wrote to members of the U.S. House and Senate to express their frustrations on May 11.
The former proprietor of a pharmacy in New Jersey was caught billing federal insurance for prescriptions of the antibiotic Dificid at $4,000 a pop, despite providers never ordering the pills. He pleaded guilty to charges of healthcare fraud conspiracy in November 2025.
The California Franchise Tax Board had charged that the rad and his sole proprietorship could be combined to constitute a "unitary business," subject to state taxation.
Experts agree that most patients younger than 65 should be treated with surgery instead of TAVR. According to a new real-world analysis, however, more and more of these patients are undergoing TAVR.
This new catheter-based device for lymphatic drainage showed early potential to be an effective treatment option for acute decompensated heart failure.
Food and Drug Administration Commissioner Marty Makary is about to become a former FDA chief. The departure comes as no surprise since President Donald Trump OK’d a plan to fire him last week.
